The Growth Investor Daily Brief

PodcastAI
  • 0.0 (0)
  • ENTREPRENEURSHIP
  • UPDATED DAILY

Get the latest updates on U.S. startups securing Series C to IPO funding, featuring key deals, top investors, and emerging industries shaping the future.

Episodes

  1. Axiado, ModifyHealth, Cleerly, and Tenstorrent: Series C+ Funding Highlights and Future Prospects

    12/06/2024

    Axiado, ModifyHealth, Cleerly, and Tenstorrent: Series C+ Funding Highlights and Future Prospects

    Michelle introduces the latest episode of The Growth Investor Daily Brief, focusing on companies that have recently secured Series C+ funding. The episode highlights Axiado's Series C funding and their strategic expansion plans, along with ModifyHealth's Series C success and their outlined growth trajectory. Additionally, Cleerly's innovative AI technology and insights into their Series C funding are discussed. The episode also covers Tenstorrent's impressive Series D round, exploring their future prospects in the industry. Michelle concludes with closing remarks and a call to action, urging listeners to stay updated on the latest trends in startup funding.

    7 min
  2. Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights

    12/05/2024

    Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights

    Michelle starts with an introduction and welcome, leading into the latest Series C+ funding highlights. The episode features Tractian's funding achievements, alongside updates on Tenstorrent and Maze Therapeutics. In between, there's a brief mention of the episode's sponsor, Acme Corp. Michelle wraps up with closing remarks, providing listeners with a comprehensive overview of these significant funding developments in the startup ecosystem.

    6 min
  3. OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans

    12/04/2024

    OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans

    Michelle welcomes listeners to the latest episode of The Growth Investor Daily Brief, diving into recent Series C+ funding updates. The episode covers OneRail's efforts in optimizing last-mile delivery and their funding plans, as well as Tenstorrent's Series D success in the AI chip sector. Additionally, Maze Therapeutics' Series D financing and their future strategic plans are discussed. The episode wraps up with investor insights, providing listeners with essential information to stay informed about the evolving investment landscape.

    6 min
  4. Halcyon and Tenstorrent: Series C and D Funding Rounds & AI Innovation Insights

    12/03/2024

    Halcyon and Tenstorrent: Series C and D Funding Rounds & AI Innovation Insights

    Michelle begins with an introduction and highlights recent Series C+ funding rounds. She delves into Halcyon's Series C funding, discussing the company's growth trajectory and strategic initiatives. The episode also covers Tenstorrent's Series D funding round, exploring their AI innovations and future funding plans. Michelle concludes with a call to action, encouraging listeners to stay informed on the latest investment trends shaping the tech industry.

    3 min
  5. Eon's $70M Series C Raise: Funding Highlights and Future Plans

    12/02/2024

    Eon's $70M Series C Raise: Funding Highlights and Future Plans

    Michelle kicks off the episode with a welcome and introduction, before diving into the latest Series C funding highlights. She focuses on Eon's impressive $70 million raise and discusses the company's future plans and strategic direction. The episode concludes with closing remarks and a call to action for listeners, encouraging them to stay engaged with the latest developments in the investment landscape.

    2 min
  6. Latest Series C+ Funding Highlights with a Spotlight on Eon

    11/28/2024

    Latest Series C+ Funding Highlights with a Spotlight on Eon

    Michelle welcomes listeners to the latest episode and highlights the latest companies securing Series C+ funding, with a special spotlight on Eon. The episode wraps up with information on how listeners can stay updated with future episodes and developments in the investment landscape.

    2 min
  7. Series C+ funding highlights: Spectro Cloud and Sirona Medical's latest successes

    11/27/2024

    Series C+ funding highlights: Spectro Cloud and Sirona Medical's latest successes

    Michelle provides an overview of the latest Series C+ funding rounds, focusing on Spectro Cloud's impressive $75 million Series C funding and its strategic growth plans. She discusses the investor interest and industry recognition that Spectro Cloud has garnered. Additionally, Michelle highlights Sirona Medical's $42 million Series C financing, emphasizing the company's product innovation in the healthcare technology sector. The episode concludes with closing remarks and a call to action for listeners.

    4 min
  8. Series C+ funding highlights: Halcyon, Lighthouse, Infinitus Systems, and Firefly Aerospace

    11/26/2024

    Series C+ funding highlights: Halcyon, Lighthouse, Infinitus Systems, and Firefly Aerospace

    Michelle presents updates on Series C+ funding, spotlighting Halcyon, Lighthouse, Infinitus Systems, and Firefly Aerospace. She delves into Lighthouse's Series C achievements with investment insights from KKR, explores Infinitus Systems' transformative AI in healthcare, and examines Firefly Aerospace's journey into Series D funding within the space industry.

    13 min
  9. Series C funding highlights: Halcyon, Lighthouse, Infinitus Systems, and KoRo Handels GmbH

    11/25/2024

    Series C funding highlights: Halcyon, Lighthouse, Infinitus Systems, and KoRo Handels GmbH

    Michelle discusses Series C funding updates, highlighting Halcyon, Lighthouse, and Infinitus Systems. She covers Lighthouse's expansion with KKR's backing, Infinitus Systems' AI healthcare innovations, and KoRo Handels GmbH's successful Series C and growth plans.

    15 min
  • 9 Episodes

About

Get the latest updates on U.S. startups securing Series C to IPO funding, featuring key deals, top investors, and emerging industries shaping the future.

Information